Which stem cells are used for Mesoblasts technology?
Mesoblast uses a type of stem cell called a Mesenchymal precursor cell (MPC) which has the ability to differentiate into a wide variety of tissues including bone, fat, heart, cartilage and other Mesenchymal lineages. In October 2006, Mesoblast was granted a United States Patent and Trade Mark Office (USPTO) United States key patent, which delivers a major commercial advantage and offers long term protection for the company’s platform technology. The patent ensures that only Mesoblast and its United States-based sister company, Angioblast Systems Inc, can commercialise the proprietary adult stem cells, termed Mesenchymal Precursor Cells, in the USA, the world’s largest market for regenerative medicines. The patent granted by the USPTO confers rights through to at least the year 2019 to composition-of-matter, or ownership, over the unique adult stem cells, which were first identified at the Hanson Institute in Adelaide , Australia .
